☰

Sean P. Flynn

Affiliations: 
University of Utah, Salt Lake City, UT 
Area:
Epilepsy, Galanin
Google:
"Sean Flynn"
Mean distance: 16.58
 
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor
H. Steve White grad student 2012 University of Utah
 (Properties of NAX-5055: A novel systemically available galanin-based neuropeptide.)
Gregory L. Holmes post-doc Dartmouth Medical School

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Blumberg BJ, Flynn SP, Barriere SJ, et al. (2016) Efficacy of nonselective optogenetic control of the medial septum over hippocampal oscillations: the influence of speed and implications for cognitive enhancement. Physiological Reports. 4
Walls AB, Flynn SP, West PJ, et al. (2016) The anticonvulsant action of the galanin receptor agonist NAX-5055 involves modulation of both excitatory- and inhibitory neurotransmission. Epilepsy Research. 121: 55-63
Flynn SP, Barriere S, Scott RC, et al. (2015) Correction: Status Epilepticus Induced Spontaneous Dentate Gyrus Spikes: In Vivo Current Source Density Analysis. Plos One. 10: e0136125
Flynn SP, Barrier S, Scott RC, et al. (2015) Status Epilepticus Induced Spontaneous Dentate Gyrus Spikes: In Vivo Current Source Density Analysis. Plos One. 10: e0132630
Holmes GL, Tian C, Hernan AE, et al. (2015) Alterations in sociability and functional brain connectivity caused by early-life seizures are prevented by bumetanide. Neurobiology of Disease. 77: 204-19
Flynn SP, White HS. (2015) Regulation of glucose and insulin release following acute and repeated treatment with the synthetic galanin analog NAX-5055. Neuropeptides. 50: 35-42
Robertson CR, Flynn SP, White HS, et al. (2011) Anticonvulsant neuropeptides as drug leads for neurological diseases. Natural Product Reports. 28: 741-62
White HS, Scholl EA, Klein BD, et al. (2009) Developing novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 6: 372-80
Bulaj G, Green BR, Lee HK, et al. (2008) Design, synthesis, and characterization of high-affinity, systemically-active galanin analogues with potent anticonvulsant activities. Journal of Medicinal Chemistry. 51: 8038-47
See more...